Hikma Pharmaceuticals Overview
- Founded
-
1978

- Status
-
Public
- Employees
-
8,700

- Stock Symbol
-
HIK

- Investments
-
21
- Share Price
-
$19.35
- (As of Monday Closing)
Hikma Pharmaceuticals General Information
Description
Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
LON
Primary Office
- 1 New Burlington Place
- London W1S 2HR
- England, United Kingdom
+44 020 0000 0000
Hikma Pharmaceuticals Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$19.35 | $19.51 | $0.40 - $36.32 | $4.26B | 220M | 883K | $1.51 |
Hikma Pharmaceuticals Financials Summary
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 4,728,277 | 7,531,560 | 8,410,786 | 6,688,814 |
Revenue | 2,550,000 | 2,553,000 | 2,341,000 | 2,207,000 |
EBITDA | 699,000 | 766,000 | 742,000 | 653,000 |
Net Income | 346,000 | 421,000 | 431,000 | 486,000 |
Total Assets | 4,747,000 | 4,372,000 | 4,135,000 | 3,930,000 |
Total Debt | 1,551,000 | 846,000 | 932,000 | 685,000 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Hikma Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Hikma Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded
Pharmaceuticals
London, United Kingdom
8,700
As of 2022
00000
000000000
00000
Hikma Pharmaceuticals Competitors (5)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Par Pharmaceutical Companies | Formerly PE-Backed | Ramapo, NY | 0000 | 000.00 | 000000&0 | 000.00 |
000 00000000000000 | Corporation | Mumbai, India | 00000 | 000000000000 | ||
000000 | Corporation | Carros, France | 0000 | 00000000 | ||
00000000 | Corporation | Basel, Switzerland | 000000 | 000000000000 | ||
000000 00000000000 | Corporation | Tokyo, Japan | 00000 | 00000000 |
Hikma Pharmaceuticals Patents
Hikma Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20100125051-A1 | Parenteral formulations comprising sugar-based esters and ethers | Granted | 19-Nov-2008 | 000000000 | 00 |
US-8541360-B2 | Parenteral formulations comprising sugar-based esters and ethers | Active | 19-Nov-2008 | 000000000 | 00 |
Hikma Pharmaceuticals Executive Team (28)
Hikma Pharmaceuticals Board Members (13)
Name | Representing | Role | Since |
---|---|---|---|
0000000 0000000 | Hikma Pharmaceuticals | Board Member | 000 0000 |
000000 0000 | Self | Board Member | 000 0000 |
0000 0000000000 | Hikma Pharmaceuticals | Board Member | 000 0000 |
00000 00000000 | Hikma Pharmaceuticals | Executive Vice Chairman and President of MENA | 000 0000 |
00000000 000 00-00000 | Self | Non-Executive Director | 000 0000 |
Hikma Pharmaceuticals Signals
Hikma Pharmaceuticals Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Hikma Pharmaceuticals Investments & Acquisitions (21)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000000 | 21-Apr-2022 | 0000000000 | 00000 | Pharmaceuticals | 00000000 |
00000000 0000 | 03-Feb-2022 | 0000000000 | 000.00 | Pharmaceuticals | 0000 0000 |
000000 000000 | 02-Jan-2019 | 0000000000 | 0000.00 | Medical Supplies | 0000 0000 |
000000 000000 | 29-Feb-2016 | 0000000000 | 00.000 | Pharmaceuticals | 0000 0000 |
EIMC United Pharmaceuticals | 08-Sep-2015 | Merger/Acquisition | 0000 | Drug Discovery |
Hikma Pharmaceuticals Subsidiaries (5)
Company Name | Industry | Location | Founded |
---|---|---|---|
Hikma Ventures | Corporate Venture Capital | London, United Kingdom | 2015 |
0000000000 | Pharmaceuticals | Carlsbad, CA | 0000 |
00000000000 | Distributors (Healthcare) | Grafelfing, Germany | 0000 |
0000 0000000000000 | Pharmaceuticals | Al Salt, Jordan | 0000 |
0000000000 | Pharmaceuticals | Casablanca, Morocco | 0000 |
Hikma Pharmaceuticals Exits (3)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000000000000 00 | 17-Sep-2014 | 000000000 00000 00 | Completed |
|
|
000 00000 00000000 | 15-Jul-2014 | 000000000000000000 | 00000 | Completed |
|
Unimark Remedies | 15-Apr-2011 | Corporate | 000.00 | Completed |